These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6508269)

  • 1. Protection by D-amino acids against growth inhibition and lysis caused by beta-lactam antibiotics.
    Tuomanen E; Tomasz A
    Antimicrob Agents Chemother; 1984 Sep; 26(3):414-6. PubMed ID: 6508269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formadicins, new monocyclic beta-lactam antibiotics of bacterial origin. I. Taxonomy, fermentation and biological activities.
    Katayama N; Nozaki Y; Okonogi K; Ono H; Harada S; Okazaki H
    J Antibiot (Tokyo); 1985 Sep; 38(9):1117-27. PubMed ID: 3934120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bactericidal activity of β-lactam antibiotics is increased by metabolizable sugar species.
    Thorsing M; Bentin T; Givskov M; Tolker-Nielsen T; Goltermann L
    Microbiology (Reading); 2015 Oct; 161(10):1999-2007. PubMed ID: 26243263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second lytic target of beta-lactam compounds that have a terminal D-amino acid residue.
    Tsuruoka T; Tamura A; Miyata A; Takei T; Inouye S; Matsuhashi M
    Eur J Biochem; 1985 Sep; 151(2):209-16. PubMed ID: 3928375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of action of beta-lactam antibiotics.
    Tipper DJ
    Rev Infect Dis; 1979; 1(1):39-54. PubMed ID: 400939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic effects of subinhibitory concentrations of beta-lactam antibiotics in vitro.
    Odenholt-Tornqvist I; Löwdin E; Cars O
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1834-9. PubMed ID: 1952854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysis enhancement: a novel form of interaction between beta-lactam antibiotics.
    Greenwood D; O'Grady F
    J Med Microbiol; 1975 Feb; 8(1):205-8. PubMed ID: 1092867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the relA gene in the autolysis of Escherichia coli induced by inhibitors of peptidoglycan biosynthesis.
    Kusser W; Ishiguro EE
    J Bacteriol; 1985 Nov; 164(2):861-5. PubMed ID: 3902801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antagonism of beta-lactam antibiotics by cefoxitin.
    Sanders CC; Sanders WE; Goering RV
    Antimicrob Agents Chemother; 1982 Jun; 21(6):968-75. PubMed ID: 6981376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the bacteriolytic effect of beta-lactam-antibiotics on Staphylococcus aureus by the polyanionic drugs suramin and Evans Blue.
    Wecke J; Franz M; Giesbrecht P
    APMIS; 1990 Jan; 98(1):71-81. PubMed ID: 2302344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperature sensitivity of bacteriolysis induced by beta-lactam antibiotics in amino acid-deprived Escherichia coli.
    Rodionov DG; Ishiguro EE
    J Bacteriol; 1998 Apr; 180(8):2224-7. PubMed ID: 9555908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The modulation of the bacteriolytic effect of beta-lactam antibiotics by non-antibiotics.
    Wecke J; Kersten T; Giesbrecht P
    APMIS Suppl; 1992; 30():32-9. PubMed ID: 1295543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion of beta-lactam antibiotics through oligomeric or monomeric porin channels of some gram-negative bacteria.
    Nitzan Y; Deutsch EB; Pechatnikov I
    Curr Microbiol; 2002 Dec; 45(6):446-55. PubMed ID: 12402087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysis of Escherichia coli by beta-lactam antibiotics: deletion analysis of the role of penicillin-binding proteins 1A and 1B.
    Yousif SY; Broome-Smith JK; Spratt BG
    J Gen Microbiol; 1985 Oct; 131(10):2839-45. PubMed ID: 3906031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative antibacterial properties in vitro of seven olivanic acid derivatives: MM 4550, MM 13902, MM 17880, MM 22380, MM 22381, MM 22382 and MM 22383.
    Basker MJ; Boon RJ; Hunter PA
    J Antibiot (Tokyo); 1980 Aug; 33(8):878-84. PubMed ID: 6968745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
    Phillips I; Warren C; Shannon K; King A; Hanslo D
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():23-31. PubMed ID: 19802967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An agar plate method for the screening of antibiotics triggering autolytic enzymes.
    Patel MV
    J Antibiot (Tokyo); 1985 Apr; 38(4):527-9. PubMed ID: 3891703
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mechanisms of resistance to beta-lactam antibiotics].
    Heesemann J
    Infection; 1993; 21 Suppl 1():S4-9. PubMed ID: 8314292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in the bacterial resistance to beta-lactam antibiotics and the ways to overcome it].
    Dutey IV
    Antibiot Khimioter; 1992 Sep; 37(9):14-6. PubMed ID: 1444659
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro antibacterial screening of six proline-based cyclic dipeptides in combination with β-lactam antibiotics against medically important bacteria.
    Kumar SN; Lankalapalli RS; Kumar BS
    Appl Biochem Biotechnol; 2014 May; 173(1):116-28. PubMed ID: 24622848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.